4//SEC Filing
Otvos James D. 4
Accession 0001209191-13-018202
CIK 0001168197other
Filed
Mar 24, 8:00 PM ET
Accepted
Mar 25, 4:28 PM ET
Size
8.0 KB
Accession
0001209191-13-018202
Insider Transaction Report
Form 4
LIPOSCIENCE INCLPDX
Otvos James D.
EVP, Chief Scientific Officer
Transactions
- Award
Common Stock
2013-03-01$9.65/sh+3,151$30,407→ 476,041 total - Award
Stock Option (right to buy)
2013-03-01+18,905→ 18,905 totalExercise: $9.65Exp: 2023-02-28→ Common Stock (18,905 underlying)
Holdings
- 180,167(indirect: By Spouse)
Common Stock
Footnotes (2)
- [F1]Represents shares issuable upon the vesting of restricted stock units granted to the reporting person on March 1, 2013. The restricted stock units vest 100% on March 1, 2016, subject to the reporting person's continuous service with the issuer as of the vesting date.
- [F2]The option vests over a period of four years, with 1/16 of the shares underlying the option vesting on a quarterly basis, starting June 1, 2013, subject to the reporting person's continuous service with the issuer as of the applicable vesting date.
Documents
Issuer
LIPOSCIENCE INC
CIK 0001168197
Entity typeother
Related Parties
1- filerCIK 0001530878
Filing Metadata
- Form type
- 4
- Filed
- Mar 24, 8:00 PM ET
- Accepted
- Mar 25, 4:28 PM ET
- Size
- 8.0 KB